May 6 |
Esperion Therapeutics Q1 2024 Earnings Preview
|
Apr 29 |
Esperion to Participate in Upcoming May Investor Conferences
|
Apr 25 |
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
Apr 23 |
Esperion to Report First Quarter 2024 Financial Results on May 7
|
Apr 21 |
11 Best Low Price Pharma Stocks To Invest In
|
Apr 8 |
Esperion stock jumps as non-statin therapy shows clinical benefits across diverse patient groups
|
Apr 7 |
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
|
Apr 1 |
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
|
Mar 28 |
Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report?
|
Mar 26 |
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
|